Literature DB >> 345342

Double-blind radiographic study of dose response to intravenous glucagon for hypotonic duodenography.

R E Miller, S M Chernish, R L Brunelle, B D Rosenak.   

Abstract

This study was undertaken to determine a dose response to glucagon during hypotonic duodenography. Fifteen male and female volunteers received placebo and 0.25 mg, 0.5 mg, 1 mg, and 2 mg of glucagon intravenously, double-blind, and crossover. Onset of drug effect occurred in approximately 45 seconds, regardless of the dose of glucagon given. There was a significant (p less than 0.01) decrease in gastrointestinal tonicity with all doses. The larger the dose, the greater the duration of drug action. Satisfactory stomach, duodenal, and small bowel hypotonicity for radiography were obtained with 0.25 to 0.5 mg of glucagon given intravenously with few side effects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 345342     DOI: 10.1148/127.1.55

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

Review 1.  Gastrointestinal radiography with glucagon.

Authors:  R E Miller; S M Chernish; R L Brunelle
Journal:  Gastrointest Radiol       Date:  1979-01-30

2.  Glucagon - its application to childhood gastrointestinal radiology.

Authors:  G A Mandell; S K Teplick
Journal:  Gastrointest Radiol       Date:  1982

3.  The minimum effective dose of glucagon in upper gastrointestinal radiography.

Authors:  D D Maglinte; L D Caudill; K L Krol; S M Chernish; D L Brown
Journal:  Gastrointest Radiol       Date:  1982

4.  Comparison of L-hyoscyamine, glucagon, and placebo for air-contrast upper gastrointestinal series.

Authors:  G Moeller; J J Hughes; F A Mangano; R Gelormini; T L Tomlinson; J A DiPalma
Journal:  Gastrointest Radiol       Date:  1992

5.  Glucagon-induced small intestinal hypotonia demonstrating bleeding lymphoma.

Authors:  H L Hecht; G M Hollenberg; A R Pradhan
Journal:  Gastrointest Radiol       Date:  1979-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.